Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity (unaudited)

v3.21.2
Condensed Consolidated Statements of Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Common Stock - Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning Balance (in shares) at Dec. 31, 2019   38,967,079        
Beginning Balance at Dec. 31, 2019 $ 1,099,512 $ 5 $ 438,591 $ 768,398 $ (1,994) $ (105,488)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Conversion of restricted stock units to common stock (net of shares of treasury stock purchased) (in shares)   38,144        
Conversion of restricted stock units to common stock (net of shares of treasury stock purchased) (578)         (578)
Settlement of stock appreciation rights in common stock (net of shares of treasury stock purchased) (in shares)   16,704        
Settlement of stock appreciation rights in common stock (net of shares of treasury stock purchased) (245)   (5)     (240)
Convertible debt extinguishment impact (net of tax impact) (17,829)   (17,829)      
Stock compensation expense 1,367   1,367      
Other comprehensive income (loss) (551)       (551)  
Net income 74,667     74,667    
Ending Balance (in shares) at Mar. 31, 2020   39,021,927        
Ending Balance at Mar. 31, 2020 1,156,343 $ 5 422,124 843,065 (2,545) (106,306)
Beginning Balance (in shares) at Dec. 31, 2019   38,967,079        
Beginning Balance at Dec. 31, 2019 1,099,512 $ 5 438,591 768,398 (1,994) (105,488)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Convertible debt extinguishment impact (net of tax impact)     (52,681)      
Net income 95,645          
Ending Balance (in shares) at Sep. 30, 2020   39,332,314        
Ending Balance at Sep. 30, 2020 1,142,957 $ 5 390,383 864,043 (897) (110,577)
Beginning Balance (in shares) at Mar. 31, 2020   39,021,927        
Beginning Balance at Mar. 31, 2020 1,156,343 $ 5 422,124 843,065 (2,545) (106,306)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Conversion of restricted stock units to common stock (net of shares of treasury stock purchased) (in shares)   230,265        
Conversion of restricted stock units to common stock (net of shares of treasury stock purchased) (2,063)         (2,063)
Settlement of stock appreciation rights in common stock (net of shares of treasury stock purchased) (in shares)   39,962        
Settlement of stock appreciation rights in common stock (net of shares of treasury stock purchased) (1,052)   (276)     (776)
Convertible debt extinguishment impact (net of tax impact) (20,860)   (20,860)      
Stock compensation expense 1,855   1,855      
Other comprehensive income (loss) 842       842  
Net income (1,685)     (1,685)    
Ending Balance (in shares) at Jun. 30, 2020   39,292,154        
Ending Balance at Jun. 30, 2020 1,133,380 $ 5 402,843 841,380 (1,703) (109,145)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Conversion of restricted stock units to common stock (net of shares of treasury stock purchased) (in shares)   23,800        
Conversion of restricted stock units to common stock (net of shares of treasury stock purchased) (1,185)         (1,185)
Settlement of stock appreciation rights in common stock (net of shares of treasury stock purchased) (in shares)   16,360        
Settlement of stock appreciation rights in common stock (net of shares of treasury stock purchased) (526)   (279)     (247)
Convertible debt extinguishment impact (net of tax impact) (13,992)   (13,992)      
Stock compensation expense 1,811   1,811      
Other comprehensive income (loss) 806       806  
Net income 22,663     22,663    
Ending Balance (in shares) at Sep. 30, 2020   39,332,314        
Ending Balance at Sep. 30, 2020 1,142,957 $ 5 390,383 864,043 (897) (110,577)
Beginning Balance (in shares) at Dec. 31, 2020   39,334,839        
Beginning Balance at Dec. 31, 2020 1,173,955 $ 5 392,247 891,211 1,160 (110,668)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Conversion of restricted stock units to common stock (net of shares of treasury stock purchased) (in shares)   254,396        
Conversion of restricted stock units to common stock (net of shares of treasury stock purchased) (10,026)         (10,026)
Settlement of stock appreciation rights in common stock (net of shares of treasury stock purchased) (in shares)   4,673        
Settlement of stock appreciation rights in common stock (net of shares of treasury stock purchased) (1,607)   (176)     (1,431)
Equity issuance (net of issuance costs) (in shares)   5,750,000        
Equity issuance (net of issuance costs) 365,280 $ 1 365,279      
Settlement of 2036 convertible senior notes conversion, net of tax impact (in shares)   2,195,836        
Settlement of 2036 convertible senior notes conversion, net of tax impact (3,237)   (26,183)     22,946
Stock compensation expense 1,844   1,844      
Other comprehensive income (loss) (1,510)       (1,510)  
Net income 39,222     39,222    
Ending Balance (in shares) at Mar. 31, 2021   47,539,744        
Ending Balance at Mar. 31, 2021 1,563,921 $ 6 733,011 930,433 (350) (99,179)
Beginning Balance (in shares) at Dec. 31, 2020   39,334,839        
Beginning Balance at Dec. 31, 2020 1,173,955 $ 5 392,247 891,211 1,160 (110,668)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 161,205          
Ending Balance (in shares) at Sep. 30, 2021   50,267,874        
Ending Balance at Sep. 30, 2021 1,675,274 $ 6 707,069 1,052,416 (924) (83,293)
Beginning Balance (in shares) at Mar. 31, 2021   47,539,744        
Beginning Balance at Mar. 31, 2021 1,563,921 $ 6 733,011 930,433 (350) (99,179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Conversion of restricted stock units to common stock (net of shares of treasury stock purchased) (in shares)   99,802        
Conversion of restricted stock units to common stock (net of shares of treasury stock purchased) (2,732)         (2,732)
Settlement of stock appreciation rights in common stock (net of shares of treasury stock purchased) (in shares)   107,095        
Settlement of stock appreciation rights in common stock (net of shares of treasury stock purchased) (6,070)   (502)     (5,568)
Settlement of 2036 convertible senior notes conversion, net of tax impact (in shares)   2,488,427        
Settlement of 2036 convertible senior notes conversion, net of tax impact (3,672)   (29,352)     25,680
Stock compensation expense 1,962   1,962      
Other comprehensive income (loss) 270       270  
Net income 79,516     79,516    
Ending Balance (in shares) at Jun. 30, 2021   50,235,068        
Ending Balance at Jun. 30, 2021 1,633,195 $ 6 705,119 1,009,949 (80) (81,799)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Conversion of restricted stock units to common stock (net of shares of treasury stock purchased) (in shares)   5,039        
Conversion of restricted stock units to common stock (net of shares of treasury stock purchased) (107)         (107)
Settlement of stock appreciation rights in common stock (net of shares of treasury stock purchased) (in shares)   27,767        
Settlement of stock appreciation rights in common stock (net of shares of treasury stock purchased) (1,401)   (14)     (1,387)
Stock compensation expense 1,964   1,964      
Other comprehensive income (loss) (844)       (844)  
Net income 42,467     42,467    
Ending Balance (in shares) at Sep. 30, 2021   50,267,874        
Ending Balance at Sep. 30, 2021 $ 1,675,274 $ 6 $ 707,069 $ 1,052,416 $ (924) $ (83,293)